Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJun 19, 2019Sn-Tetrofosmin Kit 5.0 mLLack of Processing Controls.Synthetopes Inc · D-1405-2019Class IITerminatedJun 19, 2019Sn-DTPA Kit 10 mgLack of Processing Controls.Synthetopes Inc · D-1404-2019Class IITerminatedJun 19, 2019Sn-d, l-ExametazimeLack of Processing Controls.Synthetopes Inc · D-1403-2019Class IITerminatedJun 19, 2019Sulfur Colloid Reaction Vial 1.0 mLLack of Processing Controls.Synthetopes Inc · D-1402-2019Class IITerminatedJun 19, 2019Sn-Mertiatide KitLack of Processing Controls.Synthetopes Inc · D-1401-2019Class IITerminatedJun 19, 2019Sn-DMSA solutionLack of Processing Controls.Synthetopes Inc · D-1400-2019Class IITerminatedJun 19, 2019PentreotideLack of Processing Controls.Synthetopes Inc · D-1399-2019Class ITerminatedJun 19, 2019AMIKACIN SULFATE INJECTIONNon-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL)...Heritage Pharmaceuticals, Inc. · D-1398-2019Class ITerminatedJun 19, 2019PROCHLORPERAZINE EDISYLATE INJECTIONNon-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL)...Heritage Pharmaceuticals, Inc. · D-1397-2019Class IIITerminatedJun 19, 2019LotemaxFailed Stability Specifications: Out of specification for viscosity.Bausch & Lomb · D-1396-2019Class ITerminatedJun 19, 2019Pecgen DMX Cough Suppressant ExpectorantLabeling: Incorrect Instructions; The product has been found to provide incorrect dosage information on its label due to a typographical error. The drug facts label...Novis PR, Inc. · D-1395-2019Class IIITerminatedJun 19, 2019Ondansetron InjectionFailed Impurities/Degradation Specifications.Fresenius Kabi USA, LLC · D-1386-2019Class IITerminatedJun 19, 2019Bisacodyl SuppositoriescGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1385-2019Class IITerminatedJun 19, 2019Hydrocodone Bitartrate and Homatropine Methylbromide Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1384-2019Class IITerminatedJun 19, 2019Hydrocodone Bitartrate and Homatropine Methylbromide Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1383-2019Class IITerminatedJun 19, 2019RisperiDONE Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1382-2019Class IITerminatedJun 19, 2019Cetirizine Hydrochloride Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1381-2019Class IITerminatedJun 19, 2019Cetirizine Hydrochloride Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1380-2019Class IITerminatedJun 19, 2019Anu-Med brand of Hemorrhoidal SuppositoriescGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1379-2019Class IITerminatedJun 19, 2019Hemorrhoidal SuppositoriescGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1378-2019Class IITerminatedJun 19, 2019Laxative SuppositoriescGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1377-2019Class IITerminatedJun 19, 2019Hydrocortisone Acetate SuppositoriescGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1376-2019Class IITerminatedJun 19, 2019Memantine Hydrochloride Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1375-2019Class IITerminatedJun 19, 2019Memantine Hydrochloride Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1374-2019Class IITerminatedJun 19, 2019Lactulose SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1373-2019Class IITerminatedJun 19, 2019Lactulose SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1372-2019Class IITerminatedJun 19, 2019Nasal Decongestant LiquidcGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1371-2019Class IITerminatedJun 19, 2019Diphenhist Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1370-2019Class IITerminatedJun 19, 2019Extra Action Cough SyrupcGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1369-2019Class IITerminatedJun 19, 2019Cough SyrupcGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1368-2019Class IITerminatedJun 19, 2019Kid Kare Childrens Cough/Cold LiquidcGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1367-2019Class IITerminatedJun 19, 2019Pain & Fever Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1366-2019Class IITerminatedJun 19, 2019Phenobarbital Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1365-2019Class IITerminatedJun 19, 2019Guaifenesin DAC Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1364-2019Class IITerminatedJun 19, 2019Guaifenesin AC Cough SyrupcGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1363-2019Class IITerminatedJun 19, 2019Acetic Acid Otic SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1362-2019Class IITerminatedJun 19, 2019Cetirizine HCL Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1361-2019Class IITerminatedJun 19, 2019Hyoscyamine Sulfate Elixir 0.125 mg per 5 mLcGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1360-2019Class IITerminatedJun 19, 2019Hyoscyamine Oral Drops 0.125 mg/mLcGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1359-2019Class IITerminatedJun 19, 2019Cyproheptadine Hydrochloride Syrup Oral SolutioncGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Torrent Pharma Inc · D-1358-2019